Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $82,549 - $96,527
834 Added 3.68%
23,490 $2.72 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $8,574 - $10,001
89 Added 0.39%
22,656 $2.33 Million
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $124,920 - $132,114
-1,164 Reduced 4.9%
22,567 $2.46 Million
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $7,611 - $13,883
-122 Reduced 0.51%
23,731 $2.7 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $70,762 - $101,688
1,201 Added 5.3%
23,853 $1.48 Million
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $44,305 - $64,928
-558 Reduced 2.4%
22,652 $1.81 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $56,777 - $72,145
657 Added 2.91%
23,210 $2.44 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $47,013 - $57,197
477 Added 2.16%
22,553 $2.43 Million
Q3 2021

Nov 10, 2021

BUY
$91.91 - $110.37 $83,913 - $100,767
913 Added 4.31%
22,076 $2.42 Million
Q2 2021

Aug 13, 2021

SELL
$86.24 - $95.92 $198,610 - $220,903
-2,303 Reduced 9.81%
21,163 $1.98 Million
Q1 2021

May 11, 2021

SELL
$71.83 - $95.48 $34,765 - $46,212
-484 Reduced 2.02%
23,466 $2.16 Million
Q4 2020

Feb 08, 2021

BUY
$67.0 - $84.39 $1.6 Million - $2.02 Million
23,950 New
23,950 $1.75 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.